$RGBP Long Value Play-Proven Short Term Gain Profit Opportunity Today as Regen BioPharma, Inc. Files Additional Composition of Matter Patent Application on NR2F6-Modulating Small Molecules Published on Published on December 11, 2017 https://www.linkedin.com/pulse/regen-biopharma-inc-files-additional-composition-matter-rob-kreh/?published=t